Literature DB >> 10823465

Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens.

M B Ruiz-Larrea1, C Martín, R Martínez, R Navarro, M Lacort, N J Miller.   

Abstract

Natural estrogens have much greater radical-scavenging antioxidant activity than has previously been demonstrated, with activities up to 2.5 times those of vitamin C and vitamin E. The biological significance of this finding remains to be elucidated. In this work the antioxidant activity of a range of estrogens (phenolic, catecholic and stilbene-derived) has been studied. The activity of these substances as hydrogen-donating scavengers of free radicals in an aqueous solution has been determined by monitoring their relative abilities to quench the chromogenic radical cation 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS*+). The results show that the order of reactivity in scavenging this radical in the aqueous phase is dependent on the precise estrogenic structure, with phenolic estrogens being more potent antioxidants than catecholestrogens or diethylstilbestrol. The ability of the same estrogens to scavenge lipid phase radicals has also been assessed, determined by the ex vivo enhancement of the resistance of low-density lipoprotein (LDL) to oxidation; the order of efficacy is different from that in the aqueous phase, with the phenolic estrogens estriol, estrone and 17beta-estradiol being less potent than 2-hydroxyestradiol, 4-hydroxyestradiol, or diethylstilbestrol. In this lipid-based system, phenolic estrogens were found to be unable to regenerate alpha-tocopherol from LDL subjected to oxidative stress, while at the same time 2- and 4-hydroxyestradiol significantly delayed alpha-tocopherol loss. These results indicate that the various estrogens are good scavengers of free radicals generated in both the aqueous and the lipophilic phases. The antioxidant activity of an estrogen depends not only on the hydrophilic or lipophilic nature of the scavenged radical, but also on the phenol and catechol structures of the estrogen compound.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823465     DOI: 10.1016/s0009-3084(00)00120-1

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  21 in total

Review 1.  Oxidative stress in cardiovascular disease.

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; N Santanam
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Catalase and estradiol inhibit mitochondrial protein S-glutathionylation.

Authors:  Bin Hu; Jorge Allina; Jingxiang Bai; Vivek Kesar; Joseph A Odin
Journal:  Mol Cell Biochem       Date:  2012-06-04       Impact factor: 3.396

3.  Influence of endogenous reproductive hormones on F2-isoprostane levels in premenopausal women: the BioCycle Study.

Authors:  Enrique F Schisterman; Audrey J Gaskins; Sunni L Mumford; Richard W Browne; Edwina Yeung; Maurizio Trevisan; Mary Hediger; Cuilin Zhang; Neil J Perkins; Kathleen Hovey; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2010-08-01       Impact factor: 4.897

4.  Comparison of two methods for radioiodination on the oxidizability properties of low density lipoprotein.

Authors:  J R Romero; R Martínez; O Fresnedo; B Ochoa
Journal:  J Physiol Biochem       Date:  2001-12       Impact factor: 4.158

Review 5.  The assessment of non-feminizing estrogens for use in neuroprotection.

Authors:  Kun Don Yi; Evelyn Perez; Shaohua Yang; Ran Liu; Douglas F Covey; James W Simpkins
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

6.  Relationship between serum DHEAS and oxidative stress levels of body mass index in healthy postmenopausal women.

Authors:  Burhan Goy; Murat Atmaca; Mehmet Aslan; Rıfkı Ucler; Murat Alay; Ismet Seven; Halit Demir; Mustafa Ozturk
Journal:  Redox Rep       Date:  2016-02-23       Impact factor: 4.412

7.  Energy expenditure and plasma F2-isoprostanes across the menstrual cycle.

Authors:  Carole B Rudra; Jean Wactawski-Wende; Kathleen M Hovey; Richard W Browne; Cuilin Zhang; Mary L Hediger; Enrique F Schisterman
Journal:  Med Sci Sports Exerc       Date:  2011-05       Impact factor: 5.411

Review 8.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  Status of trace elements and antioxidants in premenopausal and postmenopausal phase of life: a comparative study.

Authors:  Sabah Ansar; Tayef Alhefdhi; Ansari M Aleem
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  Balance of beneficial and deleterious health effects of quinones: a case study of the chemical properties of genistein and estrone quinones.

Authors:  Qiang Zhang; Tingting Tu; D André d'Avignon; Michael L Gross
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.